The field of bleeding disorders has seen monumental transformation. For many patients, biotech innovation has turned what was once a fatal diagnosis with a […]
Biotech innovation makes inroads against bleeding disorders Read More »
A year after a congressional commission urged strategic action to prevent China from replacing America as the world leader in biotechnology, we still have
BIO CEO hails congressional report on threat of China dominating biotech Read More »
Voters see a better path than Most Favored Nation to ensure access and affordability of innovative medicines Eight in 10 American voters would be
Poll: U.S. voters want PBM and insurance reform—and strong biotech Read More »
China gains a huge advantage in biotech competition by speeding up clinical trials, and America must respond, a member of the Board of the
BIO Board member advises Congress on China’s clinical trial competition Read More »
Reauthorization of federal seed funding, a top priority for BIO’s work with Congress, passed the House with hefty bipartisan support on March 17 and
SBIR reauthorization, a top BIO priority, is passed by Congress Read More »
Known as “America’s Medicine Cabinet,” Puerto Rico is working to maintain its leadership in U.S. biotech production by becoming a hub for reshoring pharmaceutical
BIO on the American Road in Puerto Rico: ‘Medicine Cabinet’ ready to reshore Read More »
The inaugural BIO Investment and Growth (BIG) Summit was a chance for leaders in the biotech industry to catch up on domestic and international
BIG Summit themes: Resilient investment, MFN threat, patients in the center Read More »
Washington’s healthcare policy landscape is constantly evolving, and 2026 is shaping up to be another consequential year for the biotech industry. Some developments are
BIG Summit panel breaks down risks and opportunities coming out of DC Read More »
With health care affordability a top concern for many Americans, pharmacy benefit managers (PBMs) continue to stand at the center of the debate. Working
The hidden layer of PBMs: What a recent investigation reveals Read More »
Americans are frustrated with the health care system for two reasons. First, it costs too much. But—second—it provides too little. While most of the
Nearly half of Americans say insurers’ rules on access delayed, denied, or altered care Read More »
